Medicare billing address
CMS Medicare provider billing file
2036 Schorrway Dr NwLancaster, OH 43130
CMS public data · NPI 1215154562
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Stephanie J Ott, M.D.
Specialty
Credential
M.D.
NPI
1215154562
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Stephanie J Ott, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2036 Schorrway Dr NwCMS Doctors & Clinicians file
1160 W Broad StCMS Doctors & Clinicians file
2036 Schorrway Dr NwCMS Doctors & Clinicians file
2405 N Columbus StIn the 2024 CMS provider billing file, this NPI had 258 Medicare beneficiaries and 37,698 total services. The average beneficiary age was 73, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$568,660.74
Total Medicare payment amount
$447,182.56
Medicare beneficiaries
258
Total services
37,698
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
75%
CMS beneficiary-panel share
Hyperlipidemia
72%
CMS beneficiary-panel share
Osteoporosis
40%
CMS beneficiary-panel share
Mood disorders
34%
CMS beneficiary-panel share
Diabetes
33%
CMS beneficiary-panel share
Depression
31%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, denosumab, 1 mg | 2,280 | $25.22 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 189 | $127.25 |
| Administration of chemotherapy into vein, 1 hour or less | 141 | $123.45 |
| Infusion, normal saline solution, 250 cc | 92 | $0.64 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 87 | $68.57 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 73 | $16.65 |
| Administration of chemotherapy into vein, each additional hour | 68 | $26.87 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 58 | $87.96 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 43 | $167.67 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 40 | $181.21 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1215154562. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisone | Prednisone | 181 | 284.1 | $1,208.48 |
| 2 | Methotrexate | Methotrexate Sodium | 162 | 393.9 | $6,109.40 |
| 3 | Duloxetine Hcl | Duloxetine Hcl | 146 | 251.7 | $4,272.20 |
| 4 | Gabapentin | Gabapentin | 123 | 211.2 | $1,870.68 |
| 5 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 112 | 291.2 | $8,883.68 |
| 6 | Celecoxib | Celecoxib | 101 | 213.3 | $5,131.08 |
| 7 | Leflunomide | Leflunomide | 91 | 181.7 | $7,877.51 |
| 8 | Pregabalin | Pregabalin | 55 | 93 | $2,411.72 |
| 9 | Allopurinol | Allopurinol | 54 | 133 | $377.84 |
| 10 | Tramadol Hcl | Tramadol Hcl | 50 | 60 | $296.71 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of New Mexico School Of Medicine
Graduation year
2001
Group/practice field
Lower Lights Christian Health Center Inc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.